These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
18 results:

  • 1. MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in colorectal cancer Organoids.
    Pickles OJ; Wanigasooriya K; Ptasinska A; Patel AJ; Robbins HL; Bryer C; Whalley CM; Tee L; Lal N; Pinna CMA; Elzefzafy N; Taniere P; Beggs AD; Middleton GM
    Cancer Res Commun; 2023 Aug; 3(8):1501-1513. PubMed ID: 37565053
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations.
    Thirimanne HN; Wu F; Janssens DH; Swanger J; Diab A; Feldman HM; Amezquita RA; Gottardo R; Paddison PJ; Henikoff S; Clurman BE
    Elife; 2022 Feb; 11():. PubMed ID: 35225231
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical outcomes of biliary drainage of malignant biliary obstruction due to colorectal cancer metastases: A systematic review.
    Kastelijn JB; van der Loos MA; Welsing PM; Dhondt E; Koopman M; Moons LM; Vleggaar FP
    Eur J Intern Med; 2021 Jun; 88():81-88. PubMed ID: 33931267
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inactivating mutations of class II transactivator (ciita) gene in gastric and colorectal cancers.
    Son HJ; Choi EJ; Yoo NJ; Lee SH
    Pathol Res Pract; 2020 Oct; 216(10):153110. PubMed ID: 32853948
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Implementation and first results of a mandatory, nationwide audit on liver surgery.
    van der Werf LR; Kok NFM; Buis CI; Grünhagen DJ; Hoogwater FJH; Swijnenburg RJ; den Dulk M; Dejong KCHC; Klaase JM;
    HPB (Oxford); 2019 Oct; 21(10):1400-1410. PubMed ID: 30926330
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Yang JB; Zhao ZB; Liu QZ; Hu TD; Long J; Yan K; Lian ZX
    Oncogene; 2018 Mar; 37(9):1192-1204. PubMed ID: 29238041
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
    Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous Reports.
    Zhao Y; Li X; Kong X
    Med Sci Monit; 2015 Oct; 21():3068-76. PubMed ID: 26456456
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.
    Surmann EM; Voigt AY; Michel S; Bauer K; Reuschenbach M; Ferrone S; von Knebel Doeberitz M; Kloor M
    Cancer Immunol Immunother; 2015 Mar; 64(3):357-66. PubMed ID: 25445815
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers.
    Lee J; Li L; Gretz N; Gebert J; Dihlmann S
    Oncogene; 2012 Mar; 31(10):1242-53. PubMed ID: 21804607
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ciita-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy.
    Frangione V; Mortara L; Castellani P; De Lerma Barbaro A; Accolla RS
    Int J Cancer; 2010 Oct; 127(7):1614-24. PubMed ID: 20091859
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.
    Michel S; Linnebacher M; Alcaniz J; Voss M; Wagner R; Dippold W; Becker C; von Knebel Doeberitz M; Ferrone S; Kloor M
    Int J Cancer; 2010 Aug; 127(4):889-98. PubMed ID: 20013806
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.
    Wang JD; Dong YC; Sheng Z; Ma HH; Li GL; Wang XL; Lu GM; Sugimura H; Jin J; Zhou XJ
    Oncology; 2007; 73(3-4):238-45. PubMed ID: 18424888
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
    de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
    Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epigenetic inactivation of class II transactivator (ciita) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transfection of dendritic cells (DCs) with the ciita gene: increase in immunostimulatory activity of DCs.
    Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG
    Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.